Literature DB >> 11949852

Short communication: Hepatic gene expression for gluconeogenic enzymes in lactating dairy cows treated with bovine somatotropin.

R A Pershing1, S D Moore, A C Dinges, W W Thatcher, L Badinga.   

Abstract

Eight lactating Holstein dairy cows (80 d in milk) were used to examine the effects of exogenous bovine somatotropin (bST) on hepatic contents of mRNA encoding pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK), and microsomal triglyceride transfer protein (MTP). Concentrations of bST in plasma were higher and milk production increased 20% in bST-treated cows. Liver samples from cows treated with bST had significantly higher total lipid contents than those from control cows. Although there were small numerical tendencies, neither triglyceride concentrations in liver nor nonesterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA), or glucose in plasma differed significantly between bST-treated and control cows. Short-term bST treatment had no detectable effects on contents of PC, PEPCK, and MTP mRNA in the liver. In summary, exogenous bST stimulation of milk production is not mediated through enhanced liver gluconeogenesis, but may involve partitioning of glucose and fatty acids for preferential use by the mammary gland.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949852     DOI: 10.3168/jds.S0022-0302(02)74101-5

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  2 in total

1.  Effects of non-esterified fatty acids on the gluconeogenesis in bovine hepatocytes.

Authors:  Xinwei Li; Xiaobing Li; Ge Bai; Hui Chen; Qinghua Deng; Zhaoxi Liu; Liang Zhang; Guowen Liu; Zhe Wang
Journal:  Mol Cell Biochem       Date:  2011-08-19       Impact factor: 3.396

2.  RNA-seq analysis of differential gene expression in liver from lactating dairy cows divergent in negative energy balance.

Authors:  Matthew McCabe; Sinéad Waters; Dermot Morris; David Kenny; David Lynn; Chris Creevey
Journal:  BMC Genomics       Date:  2012-05-20       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.